Hikma Pharmaceutical | HIK - Ordinary Share Capital

Stock Price
1,602.00
Daily Change
48.00 3.09%
Monthly
4.91%
Yearly
-29.80%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $40M in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Almirall EUR 214.79M 154.21 Jun/2025
AstraZeneca USD 1.55B 1.16B Sep/2025
Autolus Therapeutics Ltd USD 266.14M 16.07K Jun/2025
Bayer EUR 982.42M 0 Sep/2025
Fresenius EUR 563.24M 0 Sep/2025
Galapagos EUR 65.9M 0 Sep/2025
Genmab DKK 10M 56M Mar/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
GRIFOLS EUR 679.73M 0 Sep/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Orion EUR 140.69M 48.49M Jun/2025
Recordati EUR 205.83M 270K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 584M 0 Dec/2024